Riskpilot← Back to searchSign inGet full accessSARomics Biostructures AB
ABActiveOrg 5566884150Scheeletorget 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 200527 employees
Revenue 2024
SEK 28,8M
0% vs 2023
EBITDA margin
2.1%
-50% vs 2023
Equity ratio
50.8%
Financial strength
Net profit 2024
SEK 385K
-25% vs 2023
| Revenue | SEK 28,8M | +0% |
| EBITDA | SEK 594K | -50% |
| Net profit | SEK 385K | -25% |
| Total assets | SEK 14,4M | -8% |
| Equity | SEK 7,3M | +6% |
| Employees | 27 | — |
Legal name
SARomics Biostructures AB
Org number
5566884150
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
22 oktober 2005
Share capital
SEK 136 000
Employees
27 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska tillhandahålla forskningstjänster åt aktörer inom läkemedels- och bioteknikbranschen och därmed förenlig verksamhet. Bolaget ska också initiera och utveckla egna projekt inom medicin och livsvetenskaper, direkt eller via dotterbolag.
Address
Scheeletorget 1
Phone
+4646191276
Email
sales@saromics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 19 093 | 22 893 | 26 585 | 28 701 | 28 828 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 808 | 2 447 | 3 391 | 1 188 | 594 |
| Depreciation & amort. | −1 313 | −667 | −121 | −288 | −393 |
| EBIT | 2 495 | 1 780 | 3 270 | 900 | 201 |
| Net financials | −156 | −86 | −1 057 | 40 | 30 |
| Profit before tax | 1 737 | 1 252 | 1 893 | 672 | 531 |
| Tax | −386 | −273 | −506 | −161 | −146 |
| Net profit | 1 351 | 979 | 1 387 | 511 | 385 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 11 094 | 14 060 | 15 625 | 15 642 | 14 424 |
| Equity | 4 063 | 5 043 | 6 430 | 6 941 | 7 326 |
| Long-term debt | 658 | 333 | 133 | 0 | 1 075 |
| Short-term debt | 5 522 | 7 392 | 6 951 | 6 323 | 3 944 |
| Total debt | 6 180 | 7 725 | 7 084 | 6 323 | 5 019 |
EBITDA margin
2.1%
This company
15.8%
Market median
-87% vs market
20202024
Equity ratio
50.8%
This company
38.2%
Market median
+33% vs market
20202024
Return on equity
5.3%
This company
18.4%
Market median
-71% vs market
20202024
Net profit margin
1.3%
This company
8.1%
Market median
-84% vs market
20202024
Asset turnover
2.00×
This company
1.12×
Market median
+79% vs market
20202024
Debt / equity
0.97×
This company
0.62×
Market median
+56% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BU Chief Executive Officer | Chief Executive Officer | 2020 |
HK Chief Auditor | Chief Auditor | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2022 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SARomics Biostructures AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Ulrik Walse | Chief Executive Officer | 0 companies |
| Helene Kristina Sjöström | Chief Auditor | 0 companies |
| Sten Randahl Sörensen | Chairman | 0 companies |
| Carl Johan Kördel | Board of Directors | 0 companies |
| Arvind Mansha Hundal | Board of Directors | 0 companies |
| Jens Olof Knobe | Board of Directors | 0 companies |
| Charlotte Dyring | Board of Directors | 0 companies |
| Sven Anders Mikael Akke | Board of Directors | 0 companies |